[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@jeromeleonard5 jerome leonard
jerome leonard posts on X about poc, $srpt, $nwbo, $cure the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX -XX%
- X Month XXXXX -XX%
- X Months XXXXXX -XX%
Mentions: X #
Followers: XXXXX #
- X Week XXXXX +0.36%
- X Month XXXXX +0.91%
- X Months XXXXX +4.90%
CreatorRank: undefined #
Social Influence #
Social category influence stocks XXXXX%
Social topic influence poc 14.29%, $srpt 14.29%, $nwbo 14.29%, $cure 14.29%, $heb 14.29%, repl 14.29%, $amrnd 14.29%, $repl XXXXX%
Top accounts mentioned or mentioned by @jiantkwazi @dhovekamp42 @lucy3370 @adamfeuerstein @jmanpharmd @bradloncar @drmakaryfda @zentropy @mjlbio @zipjet @mattbiotech @jmacsi @persimmonti @banana_oncology
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Curecoin (CURE)
Top Social Posts #
Top posts by engagements in the last XX hours
"It's a bit dissappointing all around. I like the CD28 add on approach but will require lots of fine tuning and we just recycle psma target. Trop2 clinical poc data late '27 at best. ARM is just YAWN. Should have broaden the r&d efforts to other validate onc targets. Lack of this brings a dark cloud over XXX. Cash on hand won't get them that far after all"
@jeromeleonard5 on X 2025-07-25 05:16:39 UTC 2206 followers, XXX engagements
"@adamfeuerstein Youve always been good at exposing shaddy biotech management. $heb $cure $nwbo just to name a few. Unfortunately sometimes it takes many years to be proven right and by then mostly fools still around. Guess this makes $srpt very special" @jeromeleonard5 on X 2025-07-20 18:11:05 UTC 2207 followers, 1243 engagements
"@bradloncar @DrMakaryFDA So $repl got $amrn'd by the fda" @jeromeleonard5 on X 2025-07-24 06:14:58 UTC 2206 followers, XXX engagements